Skip to main content
Article
Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer
University of Massachusetts Medical School Faculty Publications
  • David H. Mulama, Kenya Medical Research Institute
  • Jeffrey A. Bailey, University of Massachusetts Medical School
  • Joslyn Foley, University of Massachusetts Medical School
  • Kiprotich Chelimo, Kenya Medical Research Institute
  • Collins Ouma, Maseno University
  • Walter G.Z.O. Jura, Maseno University
  • Juliana A. Otieno, Kenya Ministry of Health
  • John M. Vulule, Kenya Medical Research Institute
  • Ann M. Moormann, University of Massachusetts Medical School
UMMS Affiliation
Department of Medicine; Program in Bioinformatics and Computational Biology; Department of Pediatrics; Department of Quantitative Health Sciences
Publication Date
2-1-2014
Document Type
Article
Subjects
Biological Markers; Burkitt Lymphoma; Ethnic Groups; Herpesvirus 4, Human; Malaria; Sickle Cell Trait
Abstract
Endemic Burkitt lymphoma (eBL) is associated with Epstein-Barr virus (EBV) and Plasmodium falciparum coinfections. Malaria appears to dysregulate immunity that would otherwise control EBV, thereby contributing to eBL etiology. Juxtaposed to human genetic variants associated with protection from malaria, it has been hypothesized that such variants could decrease eBL susceptibility, historically referred to as "the protective hypothesis." Past studies attempting to link sickle cell trait (HbAS), which is known to be protective against malaria, with protection from eBL were contradictory and underpowered. Therefore, using a case-control study design, we examined HbAS frequency in 306 Kenyan children diagnosed with eBL compared to 537 geographically defined and ethnically matched controls. We found 23.8% HbAS for eBL patients, which was not significantly different compared to 27.0% HbAS for controls [odds ratio (OR) = 0.85; 95% confidence interval (CI) 0.61-1.17; p-value = 0.33]. Even though cellular EBV titers, indicative of the number of latently infected B cells, were significantly higher (p-value < 0.0003) in children residing in malaria holoendemic compared to hypoendemic areas, levels were not associated with HbAS genotype. Combined, this suggests that although HbAS protects against severe malaria and hyperparasitemia, it is not associated with viral control or eBL protection. However, based on receiver operating characteristic curves factors that enable the establishment of EBV persistence, in contrast to those involved in EBV lytic reactivation, may have utility as an eBL precursor biomarker. This has implications for future human genetic association studies to consider variants influencing control over EBV in addition to malaria as risk factors for eBL.
Keywords
  • UMCCTS funding
Rights and Permissions
Copyright 2013 The Authors. Published by Wiley Periodicals, Inc. on behalf of UICC. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
DOI of Published Version
10.1002/ijc.28378
Source
Mulama DH, Bailey JA, Foley J, Chelimo K, Ouma C, Jura WG, Otieno J, Vulule J, Moormann AM. Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer. Int J Cancer. 2013 Feb 1;134(3):645-53. doi: 10.1002/ijc.28378. Link to article on publisher's site
Related Resources

Link to Article in PubMed

PubMed ID
23832374
Citation Information
David H. Mulama, Jeffrey A. Bailey, Joslyn Foley, Kiprotich Chelimo, et al.. "Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer" Vol. 134 Iss. 3 (2014) ISSN: 0020-7136 (Linking)
Available at: http://works.bepress.com/ann_moormann/49/